chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vertigo
Clinical narrative: Vertigo; numb and tingling lips; numb and tingling lips; headache; chills; fever 101; Vertigo; This is a spontaneous report from a contactable consumer (patient). A 64 years old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injec-tion; Lot Number: ER8732) via an unspecified route of administration, administered in Left Arm on 27Mar2021 at 15:00 (64-year-old at vaccination) as dose 2, single for COVID-19 immunization. The patient was non-pregnant at vaccination. The patient's medical history included hypothyroidism, eczema, psoriasis, shellfish allergy, known allergies to IV contrast. Past drug included Celclor, Doxycycline, patient was allergic to both the past drugs. The patient's concomitant medication(s) included levothyroxine sodium; amitriptyline; ALLEGRA; ADVIL. Facility where the most recent COVID-19 vaccine was administered was reported at facility. The patient had no covid prior vaccination. The patient was not covid tested post vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EN6206) via an unspecified route of administration, administered in Left Arm on 06Mar2021 at 15:00 (64-year-old at vaccination) as dose 1, single for covid-19 immunization. On 27Mar2021, the patient experienced numb and tingling lips, headache, chills, fever 101, and all resolved after 1 day, vertigo lasted 5 days and had returned on 28Apr2021. The patient underwent lab tests and procedures which included body temperature of 101 on 27Mar2021. The patient had not received any treatment medication for the resulted events. Device date was reported as 28Apr2021. The outcome 2nd occurrence of vertigo was unknown, while outcome of other events was recovered on 28Apr2021.  No follow-up attempts are needed. No further information was expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling in arm; This is a spontaneous report from a non-contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 12:00 (at the age of 22-years-old), as a single dose for COVID-19 immunisation.  Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included valaciclovir hydrochloride (VALTREX) for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Apr2021 at 11:00, the patient experienced tingling in arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tingling in arm was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Abdominal pain, Computerised tomogram, Decreased appetite, Dyspepsia
Clinical narrative: Severe abdominal pain; bloating; belching; indigestion/Can not digest most fruit and vegetables except a little cooked spinach, boiled potato or yam and rice. Unable to eat poultry, meat, fish or egg.; Unable to eat; loss of appetite; This is a spontaneous report received from a contactable consumer (patient). A 60-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6205) via an unspecified route of administration in left arm on 07Mar2021 at 14:00 (at the age of 60-year-old) as single dose for COVID-19 immunization. Medical history of the patient included blood pressure, diabetes, elevated cholesterol. Patient was taking other medications/concomitant [unspecified] within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EL9266) via an unspecified route of administration in left arm on 24Feb2021 at 14:30 as single dose for COVID-19 immunization. On 21Mar2021, the patient experienced severe abdominal pain, bloating, belching, indigestion, unable to eat, loss of appetite. Patient was not able to digest most fruit and vegetables except a little cooked spinach, boiled potato or yam and rice and was unable to eat poultry, meat, fish or egg, survived a few days by eating Cheerios only. The problem was continuing for 5 weeks and medicine prescribed by doctors (primary care and Gastroenterologist) did not help. X-Ray, Ultrasound exam, computerized tomography (CT) Scan, Endoscopy failed to detect any abnormality on an unspecified date. Results of tests and procedures for investigation of the patient included: Nasal Swab with result: Negative on 20Apr2021. The adverse events result in Emergency room/department or urgent care. Patient was being treated for gastric problems in response to the adverse event. Outcome of the events were not resolved.   No follow-up attempts are needed. No further information expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Endoscopy, Eructation, Feeding disorder, Investigation, Ultrasound scan
Clinical narrative: Severe abdominal pain; bloating; belching; indigestion/Can not digest most fruit and vegetables except a little cooked spinach, boiled potato or yam and rice. Unable to eat poultry, meat, fish or egg.; Unable to eat; loss of appetite; This is a spontaneous report received from a contactable consumer (patient). A 60-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6205) via an unspecified route of administration in left arm on 07Mar2021 at 14:00 (at the age of 60-year-old) as single dose for COVID-19 immunization. Medical history of the patient included blood pressure, diabetes, elevated cholesterol. Patient was taking other medications/concomitant [unspecified] within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EL9266) via an unspecified route of administration in left arm on 24Feb2021 at 14:30 as single dose for COVID-19 immunization. On 21Mar2021, the patient experienced severe abdominal pain, bloating, belching, indigestion, unable to eat, loss of appetite. Patient was not able to digest most fruit and vegetables except a little cooked spinach, boiled potato or yam and rice and was unable to eat poultry, meat, fish or egg, survived a few days by eating Cheerios only. The problem was continuing for 5 weeks and medicine prescribed by doctors (primary care and Gastroenterologist) did not help. X-Ray, Ultrasound exam, computerized tomography (CT) Scan, Endoscopy failed to detect any abnormality on an unspecified date. Results of tests and procedures for investigation of the patient included: Nasal Swab with result: Negative on 20Apr2021. The adverse events result in Emergency room/department or urgent care. Patient was being treated for gastric problems in response to the adverse event. Outcome of the events were not resolved.   No follow-up attempts are needed. No further information expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: Severe abdominal pain; bloating; belching; indigestion/Can not digest most fruit and vegetables except a little cooked spinach, boiled potato or yam and rice. Unable to eat poultry, meat, fish or egg.; Unable to eat; loss of appetite; This is a spontaneous report received from a contactable consumer (patient). A 60-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6205) via an unspecified route of administration in left arm on 07Mar2021 at 14:00 (at the age of 60-year-old) as single dose for COVID-19 immunization. Medical history of the patient included blood pressure, diabetes, elevated cholesterol. Patient was taking other medications/concomitant [unspecified] within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EL9266) via an unspecified route of administration in left arm on 24Feb2021 at 14:30 as single dose for COVID-19 immunization. On 21Mar2021, the patient experienced severe abdominal pain, bloating, belching, indigestion, unable to eat, loss of appetite. Patient was not able to digest most fruit and vegetables except a little cooked spinach, boiled potato or yam and rice and was unable to eat poultry, meat, fish or egg, survived a few days by eating Cheerios only. The problem was continuing for 5 weeks and medicine prescribed by doctors (primary care and Gastroenterologist) did not help. X-Ray, Ultrasound exam, computerized tomography (CT) Scan, Endoscopy failed to detect any abnormality on an unspecified date. Results of tests and procedures for investigation of the patient included: Nasal Swab with result: Negative on 20Apr2021. The adverse events result in Emergency room/department or urgent care. Patient was being treated for gastric problems in response to the adverse event. Outcome of the events were not resolved.   No follow-up attempts are needed. No further information expected.
Age: 45.0
Sex: U
Vaccine: COVID19
Symptoms: Fungal infection, SARS-CoV-2 test
Clinical narrative: Yeast infection 4-6 days after 1st and 2nd dose.; This is a spontaneous report from a contactable consumer or other non hcp. A 45-years-old patient of an unspecified gender received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: ER8739), via an unspecified route of administration in Arm Left on 30Mar2021 08:00(age at vaccination: 45 years) as DOSE 1, SINGLE, second dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EW0169) via an unspecified route of administration in Arm Left on 20Apr2021 08:00(age at vaccination: 45 years) as DOSE 2, SINGLE for covid-19 immunisation. Patient didn't receive other vaccines within 4 weeks prior to vaccination, patient didn't had covid prior to vaccination. The patient medical history and concomitant medications were not reported. Patient had no allergies. The patient experienced yeast infection 4-6 days after 1st and 2nd dose on 03Apr2021. Therapeutic measures were taken as a result of yeast infection 4-6 days after 1st and 2nd dose was Monistat. The patient underwent lab tests and procedures which included sars-cov-2 test: unknown result on unspecified date. The outcome of the event fungal infection was recovering.  No follow-up attempts are Possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes under left arm; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 26Apr2021 at 09:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included asthma. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fluticasone propionate (FLOVENT), montelukast sodium (SINGULAIR) and unspecified multivitamin; all for unspecified indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 05Apr2021 at 09:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 27Apr2021, the patient experienced swollen lymph nodes under left arm. The event did not result in a visit to the doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes under left arm was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Chills, Headache
Clinical narrative: Chills; muscle and joint aches; muscle and joint aches; weakness; vomiting; headache; fever 99.5; arm pain; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 13:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, hypothyroidism, blood pressure high, high cholesterol, (unspecified) allergies, COVID-19 and allergy to sulfa drugs and latex. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), hydroxychloroquine (MANUFACTURER UNKNOWN) and leflunomide (MANUFACTURER UNKNOWN); all from unknown date for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 10:00, the patient experienced chills, muscle and joint aches, weakness, vomiting, headache, fever 99.5 and arm pain. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, muscle and joint aches, weakness, vomiting, headache, fever 99.5 and arm pain was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Pyrexia, Vomiting
Clinical narrative: Chills; muscle and joint aches; muscle and joint aches; weakness; vomiting; headache; fever 99.5; arm pain; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 13:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, hypothyroidism, blood pressure high, high cholesterol, (unspecified) allergies, COVID-19 and allergy to sulfa drugs and latex. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), hydroxychloroquine (MANUFACTURER UNKNOWN) and leflunomide (MANUFACTURER UNKNOWN); all from unknown date for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 10:00, the patient experienced chills, muscle and joint aches, weakness, vomiting, headache, fever 99.5 and arm pain. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, muscle and joint aches, weakness, vomiting, headache, fever 99.5 and arm pain was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Neck pain, Pain in jaw
Clinical narrative: Lymph node swelling at the left armpit.; Soreness at the right neck; Soreness at the left jew.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 27Apr2021 at 14:15 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was not allergic to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 06Apr2021 at 10:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 14:15, 24hrs after the vaccination, the patient experienced lymph node swelling in the left armpit, soreness in the right neck and left jaw. On 29Apr2021, 48 hours after the vaccination, the symptoms were ongoing. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events lymph node swelling in the left armpit, soreness in the right neck and left jaw was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise, Nasopharyngitis, Pain in extremity
Clinical narrative: Sore arm; Headaches; Feeling sick like a cold; Cold; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 27Apr2021 at 16:45(at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history included heart murmur and hypertension. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included escitalopram oxalate (LEXAPRO), hydroxyzine (MANUFACTURER UNKNOWN) and hydrochlorothiazide (MANUFACTURER UNKNOWN); all on unknown dates for unspecified indications. The patient had no known allergies to food, medication or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 01Apr2021 at 16:45(at the age of 19-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 00:00, the patient experienced sore arm, headaches and feeling sick like a cold. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, headaches and feeling sick and cold were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: After the second dose, 2 days after receiving it, the lymph nodes in my neck and clavicle region had swollen and were painful to touch on my left side.; After the second dose, 2 days after receiving it, the lymph nodes in my neck and clavicle region had swollen and were painful to touch on my left side.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient previously took penicillin for unknown indication on unknown date and experienced penicillin allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (age at vaccination unknown) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. After the second dose, two days after receiving it, the patients lymph nodes in her neck and clavicle region had swollen and were painful to touch on her left side on 25Apr2021. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events after the second dose, two days after receiving it, the patients lymph nodes in her neck and clavicle region had swollen and were painful to touch on her left side was resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Agitation, Cough, Diarrhoea, Dizziness, Dyspnoea
Clinical narrative: itching; swelling; dizziness; coughing; sneezing; agitation; nausea; diarrhea; trouble breathing; This is a spontaneous report from a contactable other hcp (Patient). A 42-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: ww0171) via an unspecified route of administration (age at vaccination 42-year) in Arm Left on 24Apr2021 at 11:00 AM as dose 2, single for COVID-19 immunization. Medical history included PCOS; Hypothyroid; allergies to Soy, Gluten, Fish; COVID-19; all from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took sulfur and byetta, and experienced allergies. Historical vaccine includes first dose of BNT162B2 (Lot number=ew0153) administered in left arm on 03Apr2021 at 09:15 AM as single dose for COVID-19 immunization. Reported vaccine facility type was Pharmacy or Drug Store. The patient received no other vaccine in four weeks. The patient had COVID prior vaccination. The patient not tested COVID post vaccination. On 24Apr2021 at 11:00 AM the patient experienced itching, swelling, dizziness, coughing, sneezing, agitation, nausea, diarrhea, trouble breathing. AE resulted in Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the adverse events; treatment received with clariten, singular, benadryl, lorazepam, prednisone. The clinical outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pruritus, Sneezing, Swelling
Clinical narrative: itching; swelling; dizziness; coughing; sneezing; agitation; nausea; diarrhea; trouble breathing; This is a spontaneous report from a contactable other hcp (Patient). A 42-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: ww0171) via an unspecified route of administration (age at vaccination 42-year) in Arm Left on 24Apr2021 at 11:00 AM as dose 2, single for COVID-19 immunization. Medical history included PCOS; Hypothyroid; allergies to Soy, Gluten, Fish; COVID-19; all from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took sulfur and byetta, and experienced allergies. Historical vaccine includes first dose of BNT162B2 (Lot number=ew0153) administered in left arm on 03Apr2021 at 09:15 AM as single dose for COVID-19 immunization. Reported vaccine facility type was Pharmacy or Drug Store. The patient received no other vaccine in four weeks. The patient had COVID prior vaccination. The patient not tested COVID post vaccination. On 24Apr2021 at 11:00 AM the patient experienced itching, swelling, dizziness, coughing, sneezing, agitation, nausea, diarrhea, trouble breathing. AE resulted in Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the adverse events; treatment received with clariten, singular, benadryl, lorazepam, prednisone. The clinical outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: Painful drawn out spottingepisode; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Mar2021 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in the year 2021 as a single dose for COVID-19 immunisation. On 19Apr2021 after not having a period for over a year, the patient experienced a painful drawn-out spotting episode after the second dose. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event painful drawn-out spotting episode was recovered on an unknown date in Apr2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Musculoskeletal stiffness
Clinical narrative: stiffness in neck; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 24Apr2021 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. On 24Apr2021 at 23:00, the patient experienced headache and stiffness in neck. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events headache and stiffness in neck was resolved on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Erythema, SARS-CoV-2 test, Swelling face
Clinical narrative: My face swelled; Face turned bit red; Hard to breath through my left nostril; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Apr2021 at 15:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had known allergies to penicillin (MANUFACTURER UNKNOWN), fish, seafood and kiwi. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified high blood pressure medication within two weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 09Apr2021 at 02:00, after more than 48 hours, the patient experienced face swelled and turned a bit red. It was hard to breathe through by left nostril, could not tell if the tongue swelled. Since the vaccination, the patient had been tested for COVID-19. On 24Apr2021, the patient underwent lab tests and procedures, which included COVID-19 virus test (nasal swab) and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of events face swelled and turned a bit red and hard to breathe through by left nostril were recovered on unknown date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Tonsillar disorder, Tonsillar hypertrophy
Clinical narrative: Swollen/sore tonsils; Swollen/sore tonsils; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 28Apr2021 at 14:30 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 20:45, the patient experienced swollen/sore tonsils. No therapeutic measures were taken for the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen/sore tonsils were not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Fatigue, Headache, Pain
Clinical narrative: Back ache set in about 12 hours after getting the vaccine.; minor joint pain; Woke up the following morning to body aches (lower back, right hip and knee,shoulder, headache) that lasted throughout the day.; Woke up the following morning to body aches (lower back, right hip and knee,shoulder, headache) that lasted throughout the day.; Woke up the following morning to body aches (lower back, right hip and knee,shoulder, headache) that lasted throughout the day.; Woke up the following morning to body aches (lower back, right hip and knee, shoulder, headache) that lasted throughout the day.; Headache that lasted throughout the day; Was generally tired; had a brieftemperature spike, but not highenough to be a fever.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 03Apr2021 at 09:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issue. Concomitant medications included cetirizine hydrochloride (ZYRTEC) taken for an unknown indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 22:00, about 12 hours after getting the vaccine the patient reported back ache setting in. On 03Apr2021, the patient was generally tired and had a brief temperature spike, but not high enough to be a fever. On 04Apr2021, the following morning to body aches (lower back, right hip and knee, shoulder, headache) that lasted throughout the day. The patient was mostly back to normal the following morning and still had minor joint pain and occasional headaches. No therapeutic measures were taken for these reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches (lower back, right hip and knee and shoulder) was resolved on 05Apr2021, that of tired and brief temperature spike, but not high enough to be a fever, was resolved on an unknown date in Apr2021, while that of minor joint pain/occasional headache was not resolved at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 24Apr2021 at 10:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Back ache set in about 12 hours after getting the vaccine.; minor joint pain; Woke up the following morning to body aches (lower back, right hip and knee,shoulder, headache) that lasted throughout the day.; Woke up the following morning to body aches (lower back, right hip and knee,shoulder, headache) that lasted throughout the day.; Woke up the following morning to body aches (lower back, right hip and knee,shoulder, headache) that lasted throughout the day.; Woke up the following morning to body aches (lower back, right hip and knee, shoulder, headache) that lasted throughout the day.; Headache that lasted throughout the day; Was generally tired; had a brieftemperature spike, but not highenough to be a fever.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 03Apr2021 at 09:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issue. Concomitant medications included cetirizine hydrochloride (ZYRTEC) taken for an unknown indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 22:00, about 12 hours after getting the vaccine the patient reported back ache setting in. On 03Apr2021, the patient was generally tired and had a brief temperature spike, but not high enough to be a fever. On 04Apr2021, the following morning to body aches (lower back, right hip and knee, shoulder, headache) that lasted throughout the day. The patient was mostly back to normal the following morning and still had minor joint pain and occasional headaches. No therapeutic measures were taken for these reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches (lower back, right hip and knee and shoulder) was resolved on 05Apr2021, that of tired and brief temperature spike, but not high enough to be a fever, was resolved on an unknown date in Apr2021, while that of minor joint pain/occasional headache was not resolved at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 24Apr2021 at 10:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Headache, Lethargy, Pyrexia
Clinical narrative: Lethargic; Fever of 100.2 within 4 hours; Loss of appetite; Headache; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 28Apr2021 at 07:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Patient had known allergies which were unspecified. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any medication within two weeks of COVID-19 vaccine. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 07Apr2021 at 07:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 12:30, the patient experienced fever of 100.2 within four hours, headache, lethargic, loss of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with TYLENOL. On 28Apr2021, the patient underwent Body Temperature and the result was 100.2 (UNSPECIFIED UNITS). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever of 100.2 within four hours, headache, lethargic, loss of appetite was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Fatigue, Headache, Muscular weakness
Clinical narrative: Neck stiffness; Severe bone and joint pain throughout legs, hands, feet, knees, neck.; Severe bone and joint pain throughout legs, hands, feet, knees, neck.; Pins and needle sensations in left hand; Weakness in hands; Terrible Headache; Nausea; Fatigue; Sleepiness; Difficulty thinking clearly; Tenderness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 29Apr2021 at 14:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included Lyme disease and lactose allergy. Concomitant medications included multi-vitamins, ibuprofen (MANUFACTURER UNKNOWN) and allergy medication for unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 07Apr2021 at 14:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 01May2021 at 06:00, the patient experienced neck stiffness, severe bone and joint pain throughout legs, hands, feet, knees, neck, pins and needle sensations in left hand, weakness in hands, terrible headache, nausea, fatigue, sleepiness, difficulty thinking clearly and tenderness at injection site. Patient didn't receive treatment for events. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, or emergency room/department or urgent care. The clinical outcome of the events was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Nausea, Paraesthesia, Somnolence, Thinking abnormal
Clinical narrative: Neck stiffness; Severe bone and joint pain throughout legs, hands, feet, knees, neck.; Severe bone and joint pain throughout legs, hands, feet, knees, neck.; Pins and needle sensations in left hand; Weakness in hands; Terrible Headache; Nausea; Fatigue; Sleepiness; Difficulty thinking clearly; Tenderness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 29Apr2021 at 14:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included Lyme disease and lactose allergy. Concomitant medications included multi-vitamins, ibuprofen (MANUFACTURER UNKNOWN) and allergy medication for unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 07Apr2021 at 14:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 01May2021 at 06:00, the patient experienced neck stiffness, severe bone and joint pain throughout legs, hands, feet, knees, neck, pins and needle sensations in left hand, weakness in hands, terrible headache, nausea, fatigue, sleepiness, difficulty thinking clearly and tenderness at injection site. Patient didn't receive treatment for events. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, or emergency room/department or urgent care. The clinical outcome of the events was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Neck stiffness; Severe bone and joint pain throughout legs, hands, feet, knees, neck.; Severe bone and joint pain throughout legs, hands, feet, knees, neck.; Pins and needle sensations in left hand; Weakness in hands; Terrible Headache; Nausea; Fatigue; Sleepiness; Difficulty thinking clearly; Tenderness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 29Apr2021 at 14:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included Lyme disease and lactose allergy. Concomitant medications included multi-vitamins, ibuprofen (MANUFACTURER UNKNOWN) and allergy medication for unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 07Apr2021 at 14:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 01May2021 at 06:00, the patient experienced neck stiffness, severe bone and joint pain throughout legs, hands, feet, knees, neck, pins and needle sensations in left hand, weakness in hands, terrible headache, nausea, fatigue, sleepiness, difficulty thinking clearly and tenderness at injection site. Patient didn't receive treatment for events. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, or emergency room/department or urgent care. The clinical outcome of the events was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash inside both elbows on forearm, and on stomach.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 22Apr2021 at 13:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8737) via an unspecified route of administration in the left arm on 01Apr2021 at 16:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation and also received influenza vaccine (MANUFACTURER UNKNOWN) in Aug2020 and experienced rash. Concomitant medications included biotin (MANUFACTURER UNKNOWN), cyanocobalamin (B 12), ergocalciferol (VITAMIN D), sambucus nigra (ELDERBERRY) and ascorbic acid, eucalyptus globulus oil, echinacea purpurea (ECHINACEA), all from unknown dates for unspecified indications. On 24Apr2021 at 04:00, the patient experienced rash inside both elbows, on forearm, and on stomach. Could not confirm it was from the vaccine, but had a similar reaction to the flu shot in Aug2020. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and was reported as going to allergist. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash inside both elbows, on forearm, and on stomach was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.